Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Hepatitis B | Research

Eliminating mother-to-child transmission of hepatitis B virus: practice and progress in Baoan, a national pilot district of China

Authors: Ya-Li Luo, Shuang Gao, Quan-Fu Zhang, Xian Liu, Ding-Yan Lv, Jia-Hong Chen, Wei Wang

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

While mother-to-child transmission (MTCT) of hepatitis B virus (HBV) remains a significant challenge in China, research investigating the effectiveness of the September 2017 pilot program to eliminate MTCT of HIV, syphilis, and HBV is limited. Baoan district, which has a higher-than-average rate of hepatitis B infection among pregnant women and strong support from the government, was one of six national pilot districts selected for the program. Therefore, this study aims to assess the progress and implementation of the elimination of MTCT of HBV in Baoan district over a period of 5 years.

Methods

Data was collected from the national information system for the prevention of MTCT, registration forms, and follow-up forms of pregnant women and their live births from 2018 to 2022. Joinpoint models were used to analyze changing trends over time, calculating annual percentage change (APC) and the corresponding 95% confidence interval (95%CI). Multivariate logistic regression models were used to analyze risk factors for HBV MTCT.

Results

From 2018 to 2022, the coverage of HBV screening during pregnancy increased from 98.29 to 99.55% (APC = 0.30, P = 0.012). The coverage of HBV early screening within 13 gestational weeks increased from 40.76 to 86.42% (APC = 18.88, P = 0.033). The prevalence of maternal HBV infection declined by an APC of − 3.50 (95% CI -6.28 ~ − 0.63). The coverage of antiviral therapy among high-risk pregnant women increased from 63.59 to 90.04% (APC = 11.90, P = 0.031). Coverage for timely administration of hepatitis B immunoglobulin, hepatitis B birth dose vaccine, and three-dose hepatitis B vaccination remained consistently above 97.50%. The coverage of post-vaccination serological testing (PVST) in high-risk infants was 56.15% (1352/2408), and the MTCT rate of HBV was 0.18%. Mothers with high-school education or below (OR = 3.76, 95% CI 1.04 ~ 13.60, P = 0.04) and hepatitis B e antigen (HBeAg) positivity (OR = 18.89, 95% CI 1.98 ~ 18.50, P = 0.01) had increased MTCT risk.

Conclusions

The implementation of comprehensive prevention strategies in Baoan district, including screening, treatment, and immunoprophylaxis, has proven effective in maintaining the MTCT of HBV at an extremely low level. However, it remains crucial to raise public awareness, specifically on the importance of improving the coverage of PVST for infants exposed to HBV.
Appendix
Available only for authorised users
Literature
1.
2.
Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–55.CrossRefPubMed
3.
4.
5.
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212–9.CrossRefPubMed
6.
Liu J, Wang X, Wang Q, Qiao Y, Jin X, Li Z, et al. Hepatitis B virus infection among 90 million pregnant women in 2853 Chinese counties, 2015-2020: a national observational study. Lancet Reg Health West Pac. 2021;16:100267.CrossRefPubMedPubMedCentral
7.
Liu J, Zhang S, Wang Q, Shen H. Elimination of mother-to-child transmission of hepatitis B in China: progress and challenges. Front Med. 2020;14(2):209–20.CrossRef
8.
Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):6550–7.CrossRefPubMed
9.
Cui F, Shen L, Li L, Wang H, Wang F, Bi S, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–72.CrossRefPubMedPubMedCentral
10.
Qiao Y, Su M, Song Y, Wang X, Li Z, Li Y, et al. Outcomes of the national programme on prevention of mother-to-child transmission of hepatitis B virus in China, 2016-2017. Infect Dis Poverty. 2019;8(1):65.CrossRefPubMedPubMedCentral
11.
Zhang L, Tao Y, Woodring J, Rattana K, Sovannarith S, et al. Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluation. Int J Epidemiol. 2019;48(4):1327–39.CrossRefPubMed
12.
Tang J, Luo YQ, Zhou YH. Elimination of hepatitis B virus infection in children: experience and challenge in China. Chin Med J. 2021;134(23):2818–24.CrossRefPubMedPubMedCentral
13.
14.
15.
16.
Luo Y, Tang W, Zhu N, Wang W. HBV infection and mother-to-child transmission of pregnant women in Baoan District, Shenzhen, from 2015 to 2019. Chinese Journal of AIDS &STD. 2021;27(4):423–4. (In Chinese)
17.
Yang M, Dijst M, Helbich M. Mental health among migrants in Shenzhen, China: does it matter whether the migrant population is identified by Hukou or birthplace? Int J Environ Res Public Health. 2018;15(12):2671.CrossRefPubMedPubMedCentral
18.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in Eidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7.CrossRef
19.
Zheng H, Walsh N, Lesi O, Cui F. New progress towards elimination of mother-to-child transmission of hepatitis B virus in China. Hepatol Int. 2022;16(6):1273–81.CrossRefPubMed
20.
21.
22.
Hou J, Cui F, Ding Y, Dou X, Duan Z, Han G, et al. Management algorithm for interrupting mother-to-child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2019;17(10):1929–36.e1.CrossRefPubMed
23.
24.
Liu Q, Jing W, Kang L, Liu J, Liu M. Trends of the global, regional and national incidence of malaria in 204 countries from 1990 to 2019 and implications for malaria prevention. J Travel Med. 2021;28(5):taab046.CrossRefPubMedPubMedCentral
25.
Hou J, Wang G, Wang F, Cheng J, Ren H, Zhuang H, et al. Guideline of prevention and treatment for chronic hepatitis B (2015 update). J Clin Transl Hepatol. 2017;5(4):297–318.CrossRefPubMedPubMedCentral
26.
Cui F, Woodring J, Chan P, Xu F. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China. Int J Epidemiol. 2018;47(5):1529–37.CrossRefPubMed
27.
Liu Z, Chen Z, Cui F, Ding Y, Gao Y, Han G, et al. Management algorithm for prevention of mother-to-child transmission of hepatitis B virus (2022). J Clin Transl Hepatol. 2022;10(5):1004–10.CrossRefPubMedPubMedCentral
28.
Xv LL. Investigation on the willingness of HBsAg positive mothers for their children participating in PVST and analysis of the PVST results in six provinces in China. Beijing: Chinese Center for Disease Control and Prevention; 2020.
29.
Committee on infectious diseases. Committee on fetus and newborn. Elimination of perinatal hepatitis B: providing the first vaccine dose within 24 hours of birth. Pediatrics. 2017;140(3):e20171870.CrossRef
30.
31.
Schillie S, Murphy TV, Fenlon N, Ko S, Ward JW. Update: shortened interval for postvaccination serologic testing of infants born to hepatitis B-infected mothers. MMWR Morb Mortal Wkly Rep. 2015;64(39):1118–20.CrossRefPubMed
32.
Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR-16):1–31.PubMed
33.
34.
Zheng H, Zhang GM, Chan PL, Wang FZ, Rodewald LE, Miao N, et al. Compliance among infants exposed to hepatitis B virus in a post-vaccination serological testing program in four provinces in China. Infect Dis Poverty. 2019;8(1):57.CrossRefPubMedPubMedCentral
35.
Lu Z, Zhou Y, Yan R, Deng X, Tang X, Zhu Y, et al. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China. Vaccine. 2017;35(33):4229–35.CrossRef
36.
Zhou Y, Lu Z, He H, Yan R, Deng X, Tang X, et al. Influencing factors and necessity of post-vaccination serologic testing follow-up for HBsAg-positive mothers and their infants: a 5-year prospective study in Zhejiang Province, China (2016-2020). J Viral Hepat. 2021;28(10):1413–21.CrossRefPubMed
37.
Lisker-Melman M, Khalili M, Belle SH, Terrault NA, Lin HS, Smith CI, et al. Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B. Ann Hepatol. 2020;19(4):388–95.CrossRefPubMedPubMedCentral
38.
Pande C, Sarin SK, Patra S, Kumar A, Mishra S, Srivastava S, et al. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat. 2013;20(11):801–10.CrossRefPubMed
Metadata
Title
Eliminating mother-to-child transmission of hepatitis B virus: practice and progress in Baoan, a national pilot district of China
Authors
Ya-Li Luo
Shuang Gao
Quan-Fu Zhang
Xian Liu
Ding-Yan Lv
Jia-Hong Chen
Wei Wang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-023-17500-y

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue

Research

The effect of educational intervention based on social support theory on the perceived stress caused by the covid-19 pandemic in patients with diabetes in hormozgan (2020–2021)

Research

Association between sleep disorders and physical activity in middle-aged Americans: a cross-sectional study from NHANES

Research

Relative and absolute inequalities in cerebrovascular disease mortality rates: exploring the influence of socioeconomic status and urbanization levels in Taiwan

Research

Finding the missing many: improving Tuberculosis care in Kajiado county through active case finding and community approaches

Research

Characteristics of children readmitted with severe pneumonia in Kenyan hospitals

Research

Own price elasticities of the demand for sugar-sweetened beverages in Bangladesh